Keywords
Lymphoma, Non-Hodgkin ×
Show more Keywords
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
Selected data models

You must log in to select data models for download or further analysis.

- 9/20/21 - 1 form, 7 itemgroups, 17 items, 2 languages
Itemgroups: Signed informed consent available for participation in the registry and consultation, Signed informed consent available for data transfer, data storage, and data handling ..., Storage of remaining bio material with contact for each scientific usage, Storage and use of remaining bio material for the following research projects (pseudonymized) for all NHL, Storage and use of remaining bio material for the following research projects (pseudonymized) FOR LYMPHOBLASTIC LYMPHOMA, Storage and use of remaining bio material for the following research projects (pseudonymized) FOR MATURE B-CELL LYMPHOMA, Storage and use of remaining bio material for the following research projects (pseudonymized) FOR LARGE CELL ANAPLASTIC LYMPHOMA (ALCL)
- 9/20/21 - 1 form, 17 itemgroups, 84 items, 2 languages
Itemgroups: Patient demographics, Therapy, Chemotherapy Regimen, Intrathecal therapy, Supportive therapy, Administration of medication, Comorbidity at the therapy begin, Medication duration, G-CSF, Cycle duration, Therapy discontinuation, Stem Cell Mobilization, Lab results prior to chemotherapy cycle, Lab results during interval after chemotherapy cycle, Toxicity, Intercurrent disease, Footer module
- 9/20/21 - 1 form, 18 itemgroups, 91 items, 2 languages
Itemgroups: Patient demographics, Therapy, Chemotherapy Regimen, Intrathecal therapy, Supportive therapy, Administration of medication, Comorbidity at the therapy begin, Medication duration, G-CSF, Cycle duration, Therapy discontinuation, Stem Cell Mobilization, Lab results prior to chemotherapy cycle, Lab results during interval after chemotherapy cycle, Toxicity, Hematopoietic Regeneration, Intercurrent disease, Footer module
- 9/20/21 - 1 form, 17 itemgroups, 83 items, 2 languages
Itemgroups: Patient demographics, Therapy, Chemotherapy Regimen, Intrathecal therapy, Supportive therapy, Administration of medication, Comorbidity at the therapy begin, Medication duration, G-CSF, Cycle duration, Therapy discontinuation, Stem Cell Mobilization, Lab results prior to chemotherapy cycle, Lab results during interval after chemotherapy cycle, Toxicity, Intercurrent disease, Footer module
- 9/20/21 - 1 form, 13 itemgroups, 66 items, 2 languages
Itemgroups: Patient demographics, Therapy, Chemotherapy Regimen Dosage, Supportive therapy, Administration of medication, Comorbidity at the therapy begin, Cycle duration, Therapy discontinuation, Lab results prior to chemotherapy cycle, Lab results during interval after chemotherapy cycle, Toxicity, Intercurrent disease, Footer module
- 9/20/21 - 1 form, 17 itemgroups, 86 items, 2 languages
Itemgroups: Patient demographics, Therapy, Chemotherapy Regimen, Intrathecal therapy, Supportive therapy, Administration of medication, Comorbidity at the therapy begin, Medication duration, G-CSF, Cycle duration, Therapy discontinuation, Stem Cell Mobilization, Lab results prior to chemotherapy cycle, Lab results during interval after chemotherapy cycle, Toxicity, Intercurrent disease, Footer module
- 9/20/21 - 1 form, 17 itemgroups, 83 items, 2 languages
Itemgroups: Patient demographics, Therapy, Chemotherapy Regimen, Intrathecal therapy, Supportive therapy, Administration of medication, Comorbidity at the therapy begin, Medication duration, G-CSF, Cycle duration, Therapy discontinuation, Stem Cell Mobilization, Lab results prior to chemotherapy cycle, Lab results during interval after chemotherapy cycle, Toxicity, Intercurrent disease, Footer module
- 9/20/21 - 1 form, 10 itemgroups, 41 items, 2 languages
Itemgroups: Patient demographics, Therapy, Chemotherapy Regimen, Intrathecal therapy, Supportive therapy, Administration of medication, Comorbidity at the therapy begin, Medication duration, Intercurrent disease, Footer module